Basket

  Untick selected:   0
  1. Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials / Alice Gottlieb ... [et al.]. XIV. kongres slovenských a českých dermatovenerológov s medzinárodnou účasťou S. 19-20
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.